SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-23-007307
Filing Date
2023-04-28
Accepted
2023-04-28 17:00:23
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A krbp-20221231x10ka.htm   iXBRL 10-K/A 351072
2 EX-31.1 krbp-20221231xex31d1.htm EX-31.1 5795
3 EX-31.2 krbp-20221231xex31d2.htm EX-31.2 5879
  Complete submission text file 0001558370-23-007307.txt   616735

Data Files

Seq Description Document Type Size
4 EX-101.SCH krbp-20221231.xsd EX-101.SCH 4135
5 EX-101.DEF krbp-20221231_def.xml EX-101.DEF 32575
6 EX-101.LAB krbp-20221231_lab.xml EX-101.LAB 25848
7 EX-101.PRE krbp-20221231_pre.xml EX-101.PRE 16356
9 EXTRACTED XBRL INSTANCE DOCUMENT krbp-20221231x10ka_htm.xml XML 8496
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39619 | Film No.: 23867907
SIC: 2836 Biological Products, (No Diagnostic Substances)